Prakt. lékáren. 2014; 10(6): 229-232

Current phytotherapeutic options in the treatment of diabetes mellitus

David Koupý1, Hana Kotolová2, Jana Kučerová1,3
1 Masarykova Univerzita, Lékařská fakulta, Farmakologický ústav, Brno
2 Veterinární a Farmaceutická Univerzita Brno, Farmaceutická fakulta, Ústav humánní farmakologie a toxikologie, Brno
3 Masarykova Univerzita, CEITEC &ndash, Středoevropský technologický institut, Brno

Diabetes mellitus is a chronic metabolic disease characterized by hyperglycaemia caused either by lowered pancreatic production of

insulin or peripheral tissue resistance to its effects. In addition to standard therapeutic strategies such as diet, administration of oral

antidiabetic agents or insulin, there are hundreds of medicinal herbs potentially applicable for adjuvant treatment of type 2 diabetes

mellitus. The aim of this work is to provide a literature survey of pharmacological effects of herbal drugs contained in tea blends for diabetics,

summary of their pharmacologically active substances and evidence of their effects compared with standard pharmacotherapy

based on recent research findings.

Keywords: diabetes mellitus, phytotherapy, herbal drugs

Published: December 16, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koupý D, Kotolová H, Kučerová J. Current phytotherapeutic options in the treatment of diabetes mellitus. Praktické lékárenství. 2014;10(6):229-232.
Download citation

References

  1. SÚKL. Souhrn údajů o přípravku - Diabetan. 2011 [cited 2013 26. 3.]; Available from: http://www.sukl.cz/modules/medication/download.php?file=SPC23256.pdf&type=spc&as=diabetan-spc.
  2. Mooney MH, S Fogarty, C Stevenson, et al. Br J Pharmacol. 2008; 153: 1669-1677. Go to original source... Go to PubMed...
  3. Mika K, Fytoterapia pre lekárov1991, Martin: Osveta. 381.
  4. Jayaprakasam B, SK Vareed, LK Olson, et al. J Agric Food Chem. 2005; 53: 28-31. Go to original source... Go to PubMed...
  5. Tsuda T, Y Ueno, H Kojo, et al. Biochim Biophys Acta. 2005; 1733: 137-147. Go to original source... Go to PubMed...
  6. Takikawa M, S Inoue, F Horio, et al. J Nutr. 2010; 140: 527-533. Go to original source... Go to PubMed...
  7. McDougall GJ, NN Kulkarni, and D Stewart. Biofactors. 2008; 34: 73-80. Go to original source... Go to PubMed...
  8. Ali M, KK Al-Qattan, F Al-Enezi, et al. Prostaglandins Leukot Essent Fatty Acids. 2000; 62: 253-259. Go to original source... Go to PubMed...
  9. Ganapathy Saravanana PP, Gandhipuram Periasamy Senthilkumarb, Thatchinamoorthi Rajarajand. Journal of functional foods. 2009; 1: 336-340. Go to original source...
  10. Shanmugasundaram E, Rajeswari G, Baskaran K, et al. J Ethnopharmacol. 1990; 30: 281-294.
  11. Ramkumar KM, Vijayakumar RS, Ponmanickam P, et al. Basic Clin Pharmacol Toxicol. 2008; 103: 538-545. Go to original source... Go to PubMed...
  12. Daisy P, J Eliza, and KA Mohamed Farook. J Ethnopharmacol. 2009; 126: 339-344. Go to original source... Go to PubMed...
  13. Kurihara Y. Crit Rev Food Sci Nutr. 1992; 32: 231-252. Go to original source... Go to PubMed...
  14. Luo H, LF Wang, T Imoto, et al. World J Gastroenterol. 2001; 7: 9-15. Go to original source... Go to PubMed...
  15. Sugihara Y, H Nojima, H Matsuda, et al. J Asian Nat Prod Res. 2000; 2: 321-327. Go to original source... Go to PubMed...
  16. Leung L, R Birtwhistle, J Kotecha, et al. Br J Nutr. 2009; 102: 1703-1708. Go to original source... Go to PubMed...
  17. Krawinkel MB and GB Keding. Nutr Rev. 2006; 64: 331-337.
  18. Chuang CY, Hsu C, Chao CY, et al. Journal of Biomedical Science. 2006; 13: 763-772. Go to original source... Go to PubMed...
  19. Basch E, S Gabardi, and C Ulbricht. Am J Health Syst Pharm. 2003; 60: 356-359. Go to original source... Go to PubMed...
  20. Ojewole JA, SO Adewole, and G Olayiwola. Cardiovasc J S Afr. 2006; 17: 227-232.
  21. Nerurkar PV, YK Lee, and VR Nerurkar. BMC Complement Altern Med. 2010; 10: 34. Go to original source... Go to PubMed...
  22. Kimura T, K Nakagawa, H Kubota, et al. J Agric Food Chem. 2007; 55: 5869-5874. Go to original source... Go to PubMed...
  23. Gopalpura P. B JC, Dubey S. Int J Diab Dev Ctries. 2009; 27: 41-45. Go to original source...
  24. Broca C, Gross R, Petit P, et al. Am J Physiol. 1999; 277: E617-623.
  25. Omoruyi FO. Plant Foods for Human Nutrition. 2008; 63: 135-140.
  26. Pari L, Monisha P, Mohamed Jalaludeen A. European Journal of Pharmacology. 2012; 691: 143-150. Go to original source... Go to PubMed...
  27. Zhou J, Chan L, Zhou S. Current Medicinal Chemistry. 2012; 19: 3523-3531.
  28. Jarvill-Taylor KJ, Anderson RA, Graves DJ. J Am Coll Nutr. 2001; 20: 327-336. Go to original source... Go to PubMed...
  29. Anderson RA, Broadhurst CL, Polansky MM, et al. J Agric Food Chem. 2004; 52: 65-70. Go to original source... Go to PubMed...
  30. Shang W, Yang Y, Zhou L, et al. J Endocrinol. 2008; 198: 561-569.
  31. Park S, IS Ahn, DY Kwon, et al. Biosci Biotechnol Biochem. 2008; 72: 2815-2823. Go to original source... Go to PubMed...
  32. Attele AS, Zhou YP, Xie JT, et al. Diabetes. 2002; 51: 1851-1858.
  33. Cho WC, Chung WS, Lee SK, et al. Eur J Pharmacol. 2006; 550: 173-179.
  34. Park MW, Ha J, Chung SH. Biol Pharm Bull. 2008; 31: 748-751.
  35. Wen-Kung Lee S-TK, I-Min Liu, Juei-Tang Cheng. Clinical and Experimental Pharmacology and Physiology. 2006; 33: 27-32. Go to original source... Go to PubMed...
  36. Hwang JT, Kim SH, Lee MS, et al. Biochem Biophys Res Commun. 2007; 364: 1002-1008. Go to original source... Go to PubMed...
  37. Benzie IFF, Wachtel-Galor S, Herbal Medicine: Biomolecular and Clinical Aspects, 2011, CRC Press: Boca Raton (FL). Go to original source...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.